Clinical Trial Update: Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating subcutaneous semaglutide for improving kidney transplant candidacy in patients with chronic kidney disease and diabetic kidney diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease
• Obesity
• Type 2 Diabetes Mellitus in Obese

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Geisinger Clinic | Conditions: CKD, Diabetic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-02-09